Annals of Family Medicine
NOVEMBER 20, 2024
Little is known about the characteristics of physicians and patients participating in boutique clinic practice models. This study offers insight into the practice patterns of boutique clinic primary care physicians, as well as the estimated public costs of this business model in Ontario. Study Design and Analysis.
Annals of Family Medicine
NOVEMBER 20, 2024
Outcome Measures Responses to questions about 1) receiving an HPV test, 2) receiving a Pap test, 3) receiving co-testing (both HPV and Pap test), and 4) being told by the clinic what kind of screening test was administered. These factors will be discussed in the presentation. and 94.9%, respectively, with no significant difference.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 18, 2025
Cost-sharing and education may improve access to GLP-1 therapies for obesity, but systemic barriers remain, requiring broader policy and clinical reforms. Other Persistent Barriers & Potential Solutions In another article not presented at the meeting, Stephanie W. They published their insights in Nature Medicine.
Integrated Care News by CFHA
MAY 8, 2025
Below is a summary of the findings published in that review, which includes structural and operational approaches as well as interventions for clinical encounters. Providing incentives such as tying vaccination to insurance-related or public benefits or offering small monetary or non-monetary incentives can also improve vaccine uptake.
Physician's Weekly
JUNE 16, 2025
The survey presented two patient vignettes and analyzed the respondents’ preferred treatment choices for patients with cardiac risk, use of cardioprotective strategies, post-treatment surveillance, and willingness to participate in clinical trials. 32% would routinely order a post-treatment echocardiogram.
Physician's Weekly
JUNE 25, 2025
I’m the Vice Chairman of Rheumatology at the Cleveland Clinic and the co-director of the Center for Vasculitis Care and Research. And I’m here today to talk about giant cell arteritis in clinical practice. So always important to consider the clinical context and patient symptoms there. Hello everyone.
The Medical Futurist
MAY 12, 2025
Some 3D printed drugs made strides some years ago by getting FDA approvals and undergoing clinical trials. AI models, such as those developed by Benevolent AI , can analyse significant amounts of datasets from scientific literature, clinical records and chemical databases in a more time efficient manner than humans can.
Expert insights. Personalized for you.
130 
Let's personalize your content